Psychedelics Around the World in 2026: Where Psilocybin, LSD & MDMA Are Legal, Decriminalized, or Medically Available

Updated August 14, 2026. Psychedelic law is changing quickly, but one of the biggest sources of confusion is the word “legal.” A substance can be illegal for ordinary possession while still being available in a clinical trial, through a special medical authorization, or under a narrow religious exemption. Decriminalization is also not the same as legalization.

Is there a country where psychedelics are simply “free” or fully legal?

For psilocybin, LSD and MDMA, the answer is generally no. There is no major national model in which all three are freely legal for unrestricted personal purchase and use. What exists instead is a patchwork of prohibited use, decriminalized personal possession, medical access, research access, and culturally or religiously protected practices.

Australia: limited medical access, not general legalization

Australia has one of the clearest regulated medical pathways. Since July 2023, specifically authorized psychiatrists may prescribe MDMA for post-traumatic stress disorder and psilocybin for treatment-resistant depression under the Therapeutic Goods Administration’s Authorised Prescriber framework. The TGA still describes these products as unapproved medicines, and access is tightly controlled. Other uses remain prohibited or subject to stricter scheduling. LSD is not included in this special prescribing pathway.

Switzerland: exceptional medical and research licences

Switzerland does not have general legal psychedelic use. The Federal Office of Public Health can issue exceptional licences for prohibited narcotics for scientific research and limited medical use. Official guidance specifically identifies hallucinogens such as LSD and psilocybin, as well as MDMA, as substances requiring exceptional authorization. For medical use, a treating physician must apply and the patient must meet strict criteria.

Portugal: decriminalized possession does not mean legal sale

Portugal is often described online as a country where “drugs are legal.” That is inaccurate. Under Portugal’s decriminalization model, possession of small amounts for personal use is generally handled as an administrative matter rather than a criminal offence. Trafficking and unauthorized supply remain illegal. There is no ordinary legal retail market for LSD, MDMA or psilocybin comparable to a licensed pharmacy or cannabis store.

The Netherlands: mushrooms are prohibited; the truffle story is more complicated

The Netherlands is another country frequently described too simply. Hallucinogenic mushrooms containing psilocybin or psilocin were added to List II of the Dutch Opium Act in 2008, while psilocybin and psilocin themselves are controlled. Official Dutch parliamentary material has historically distinguished psychedelic sclerotia, commonly called truffles, from the prohibited mushrooms. This narrow distinction should not be confused with full legalization of psilocybin as a drug.

Canada: controlled substances with limited legal pathways

In Canada, psilocybin and MDMA remain controlled substances. Legal access may occur in authorized clinical trials, through the Special Access Program in appropriate cases, or through specific exemptions under the Controlled Drugs and Substances Act. These pathways do not make commercial mushroom stores or unsupervised personal use legal. Canadian controlled-substance regulations are also changing, so any legal statement should be checked against current Health Canada guidance.

Brazil and Peru: traditional plant practices are a different legal category

Some countries recognize specific traditional or religious practices without broadly legalizing psychedelics. Brazil has a national framework for religious use of ayahuasca. Peru recognizes traditional knowledge and uses of ayahuasca by Amazonian Indigenous communities as Cultural Heritage of the Nation. These protections are culturally specific and should not be interpreted as permission for unrestricted commercial use of every psychedelic substance.

The most useful way to read psychedelic law

When comparing countries, ask four separate questions: Is possession a criminal offence? Is personal possession decriminalized? Is a medical pathway available? Is a religious, cultural or research exemption available? A country can answer “yes” to one and “no” to the others.

Sources checked

Therapeutic Goods Administration of Australia; Swiss Federal Office of Public Health; Portuguese Law 30/2000 and European drug-policy materials; Dutch Opium Act and official parliamentary records; Health Canada controlled-substance guidance; Brazil CONAD Resolution 1/2010; Peru Ministry of Culture and National Institute of Health. This article is educational and is not legal advice.